Denali Therapeutics (DNLI) Other Gross PP&E Adjustments (2017 - 2026)

Denali Therapeutics (DNLI) reported Other Gross PP&E Adjustments of -$47.6 million for Q1 2026, up 5.15% year-over-year from -$45.3 million in Q1 2025, and down 6291.41% on a QoQ basis from -$745000.0 in Q4 2025.

Denali Therapeutics (DNLI) has 10 years of Other Gross PP&E Adjustments data on file, last reported at -$47.6 million in Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 5.15% year-over-year to -$47.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.6 million (up 5.15% YoY) and the FY2025 annual result came in at -$745000.0, down 137.65% from the prior year.
  • Other Gross PP&E Adjustments slipped to -$47.6 million in Q1 2026 per DNLI's latest filing, from -$745000.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $38.4 million in Q4 2023 and bottomed at -$50.2 million in Q1 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$26.8 million (2023), against an average of -$21.5 million.
  • The widest annual swing landed in 2023, when Other Gross PP&E Adjustments jumped 500.22%; it then plunged 137.65% in 2025.
  • Tracing DNLI's Other Gross PP&E Adjustments over 5 years: stood at $6.4 million in 2022, then jumped by 500.22% to $38.4 million in 2023, then slumped by 94.84% to $2.0 million in 2024, then sank by 137.65% to -$745000.0 in 2025, then tumbled by 6291.41% to -$47.6 million in 2026.
  • Per Business Quant, the three latest DNLI Other Gross PP&E Adjustments figures stand at -$47.6 million (Q1 2026), -$745000.0 (Q4 2025), and -$20.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Denali Therapeutics 3.82 Bn 3.82 Bn - -47.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -47.62 Mn
Mar 31, 2026 -47.62 Mn
Dec 31, 2025 -745,000.00
Dec 31, 2025 -745,000.00
Sep 30, 2025 -20.04 Mn
Sep 30, 2025 -20.04 Mn
Jun 30, 2025 -47.40 Mn
Jun 30, 2025 -47.40 Mn
Mar 31, 2025 -50.20 Mn
Mar 31, 2025 -50.20 Mn
Dec 31, 2024 1.98 Mn
Dec 31, 2024 1.98 Mn
Sep 30, 2024 -23.72 Mn
Sep 30, 2024 -23.72 Mn
Jun 30, 2024 -24.53 Mn
Jun 30, 2024 -24.53 Mn
Mar 31, 2024 -25.31 Mn
Mar 31, 2024 -25.31 Mn
Dec 31, 2023 38.37 Mn
Dec 31, 2023 38.37 Mn
Sep 30, 2023 -26.75 Mn
Sep 30, 2023 -26.75 Mn
Jun 30, 2023 -27.42 Mn
Jun 30, 2023 -27.42 Mn
Mar 31, 2023 -28.05 Mn
Mar 31, 2023 -28.05 Mn
Dec 31, 2022 6.39 Mn
Dec 31, 2022 6.39 Mn
Sep 30, 2022 -31.27 Mn
Sep 30, 2022 -31.27 Mn
Jun 30, 2022 -29.76 Mn
Jun 30, 2022 -29.76 Mn
Mar 31, 2022 -30.26 Mn
Mar 31, 2022 -30.26 Mn
Dec 31, 2021 7.28 Mn
Dec 31, 2021 7.28 Mn
Sep 30, 2021 -31.20 Mn
Sep 30, 2021 -31.20 Mn
Jun 30, 2021 -31.62 Mn
Jun 30, 2021 -31.62 Mn
Mar 31, 2021 -32.24 Mn
Mar 31, 2021 -32.24 Mn
Dec 31, 2020 10.32 Mn
Dec 31, 2020 10.32 Mn
Sep 30, 2020 -32.98 Mn
Sep 30, 2020 -32.98 Mn
Jun 30, 2020 -33.31 Mn
Jun 30, 2020 -33.31 Mn
Mar 31, 2020 -33.63 Mn
Mar 31, 2020 -33.63 Mn
Dec 31, 2019 15.57 Mn
Dec 31, 2019 15.57 Mn
Sep 30, 2019 -34.34 Mn
Sep 30, 2019 -34.34 Mn
Jun 30, 2019 -34.65 Mn
Jun 30, 2019 -34.65 Mn
Mar 31, 2019 -34.40 Mn
Mar 31, 2019 -34.40 Mn
Dec 31, 2018 33.87 Mn
Dec 31, 2018 33.87 Mn
Dec 31, 2017 18.86 Mn
Dec 31, 2017 18.86 Mn